OAGULATION FACTOR XI11 is a plasma transgluta-C minase consisting of two catalytic a-subunits and two noncatalytic b-subunits.'" The a,b, heterotetramer circulates in blood in a complex with fibrinogen. In the final stages of blood coagulation, the newly generated thrombin cleaves an activation peptide from the amino terminus of the a-subunit of factor XIII. The modified a-subunit then dissociates from the b-subunit and the active site in the asubunit is exposed in the presence of calcium ions. Factor XIIIa (activated factor XIII) catalyzes intermolecular crosslinking reactions between fibrin monomers themselves, between fibrin and a,-plasmin inhibitor, and between fibrin and fibronectin. These reactions lead to an increase in the mechanical strength ofthe fibrin clot, an increase in its resistance to proteolytic degradation, and the assembly of an extracellular matrix. Accordingly, deficiency of factor XI11 results in a life-long bleeding tendency and abnormal wound healing in affected patients, and spontaneous abortion in affected female^.^,^ At present, more than 200 cases of factor XI11 deficiency in the world have been identified, but almost all are deficient in the a-subunit. Since the a-subunit cames the active site of the enzyme, its deficiency leads directly to a defective cross-linking reaction. Recently, a patient with complete deficiency of the b-subunit has been found in Japan.5 She also had a reduced plasma level of the a-subunit accompanied by a mild bleeding tendency, It is likely that a lack of the b-subunit results in the loss of the a-subunit because of its resultant instability.
The amino acid sequences of the a-and b-subunits of factor XI11 have been established by a combination of cDNA cloning and amino acid sequence analy~is.~-~ The a-subunit consists of 73 1 amino acids, while the 6-subunit is composed of 641 residues that form 10 tandem repeats called Sushi domains." Determination of the genomic organization and sequence for both subunits",'2 has made it possible to characterize factor XI11 deficiency at the DNA level. In this study, we have examined a genomic DNA obtained from the patient with complete 6-subunit deficiency mentioned previously, and found that she is a compound heterozygote with two different alleles containing defective b-subunit genes.
MATERIALS AND METHODS
Venous blood was drawn from normal individuals, apatient with b-subunit deficiency,' and her daughter and 'son after informed and the destruction of a disulfide bond in the seventh Sushi domain. This mutation was also confirmed by cleavage with Mboll endonuclease. Thus, the proband turned out to be a compound heterozygote of two separate defective alleles. Although half of the amplified DNAs for exon Vlll of her daughter or son were cleaved by Mboll, those for intron A were not cleaved by Taql. The replacement of guanosine-I 1499 by thymidine in their exon Vlll has also been confirmed by sequence analysis, indicating that they are heterozygous for one normal and one defective allele.
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consent had been obtained. Genomic DNA samples were prepared from leukocytes by standard techniques. l 3 Southern blotting. Ten micrograms of a genomic DNA was digested with 20 U of EcoRI restriction enzyme at 37°C for 2 hours, and applied to a 0.4% Agarose gel (International Biotechnologies) and electrophoresed at 1.5 V/cm overnight. The DNA fragments were transferred to a nylon membrane (StrataGene) using a vacuum blotter (Pharmacia). The membrane was hybridized overnight at 65°C with a 32P-labeled cDNA of 2.2 kb8 encoding the b-subunit and then washed with 0.1 X SSC (1 X SSC = 0.15 mol/L NaCl + 0.015 mol/L sodium citrate) and 0.1% sodium dodecyl sulfate (SDS). The membrane was exposed to XAR-5 film (Eastman Kodak, Rochester, NY) at -70°C for 5 days.
In vitro amplification. One microgram of a genomic DNA was amplified in a 100-pL reaction mixture as de~cribedl~.~' using 2.5 to 5.0 U of Thermiis aquaticus DNA polymerase (Promega). After 30 cycles of amplification, 9 p L of each reaction mixture was applied to a 0.8% Agarose gel containing ethidium bromide (0.5 rg/mL) in 1 X TBE buffer (89 mmol/L TRIS base/89 mmol/L boric acid/20 mmol/L EDTA, pH 7.8). Oligonucleotides were prepared with an Applied Biosystems' synthesizer. For amplification, a total of eight pairs of gene-specific primers were designed from the nucleotide sequence of the normal b-subunit gene'' as listed in Table 1 .
Nucleotide sequence analysis. The amplified DNA samples were digested with restriction enzymes to generate the proper ends for ligation into sequencing vectors. The digested samples were applied to a 0.8% Agarose gel, electroeluted, and then subcloned into M 1 3mp I8 or M I3mp 19 (Bethesda Research Laboratories) with restriction sites to obtain discrete sequences. The DNA sequence of an insert was then obtained using the dideoxynucleotide method16 were examined. Accordingly, both normal and mutated nucleotide sequences at the same position in a single genomic DNA sample were identified in each amplified region, and confirmed by restriction enzyme digestion when convenient restriction sites were available.
Detection of type I and 11 mutations by restriction digestion. For restriction enzyme analysis for the deletion of adenosine-4 I6 1 (nucleotide number in Bottenus et al") at the acceptor splice site of intron A (type I mutation), 18 p L of the DNA sample amplified by pair 7 was incubated with 7 U of TuqI endonuclease (Promega) for 90 minutes at 65°C. For the detection ofthe replacement ofguanosine-1 1499 by thymidine in exon VI11 (type I1 mutation), the DNA amplified by pair 8 was incubated with 10 U ofMboII endonuclease (New England Biolabs) for 90 minutes at 37°C. After digestion, half of each sample was applied to a 0.8% Agarose gel or to a 2% NuSieve/ I% SeaKem Agarose (FMC BioProducts) gel.
RESULTS AND DISCUSSION

Genomic Southern blotting analysis and in vitro amplijication of the b-subunit gene. Southern blotting analysis
showed that EcoRI-digested genomic DNAs of the proband, her daughter and son, and a normal individual showed the exact pattern (data not shown) as predicted from the gene structure for the b-subunit.12 Thus, no gross changes in the 6-subunit gene were detected. This method cannot exclude a possible complete deletion of one of two b-subunit alleles; however, that was not the case in this study, because the presence of two different alleles in the proband's DNA were confirmed in each amplified region (Fig 1) . It was also concluded that each of the two alleles contained a separate genetic defect.
Six pairs of specific amplification primers were used for in vitro amplification of all 12 exons and their boundaries of the b-subunit gene in the proband's DNA (Table 1, Fig 1) . Pairs 1 through 6 produced 2.1-, 2.5-, 2.9-, 2.0-, 2.3-, and I .7-kb DNA fragments, respectively (data not shown); the sizes of these fragments were exactly the same as predicted from the normal genomic sequence." These results reconfirmed that there were no gross changes in the probands gene.
Deletion of adenosine-4161 at an intron/exon boundary. Nucleotide sequences of the six amplified fragments were then examined to find possible small differences from the normal sequence. Approximately 15.5 kb of a total of 28 kb for the gene coding for the 6-subunit were sequenced in this study. When 12 DNA samples from the proband spanning the intron A/exon I1 boundary region were sequenced, half of the samples showed a normal sequence of TTTCAGAG, while the remaining samples showed T T T C O G A G (Fig 2) . This deletion of adenosine-4 I6 1 (type I mutation) falls exactly at the acceptor splice site of intron A where the obligatory AG is located. This sequence is essential for the normal processing of premRNAs. Therefore, a failure in the normal splicing of intron A may lead to the formation of a peptide consisting of only six amino acids, since there is a potential stop codon of TAA 15 bp downstream of exon I (Fig 3A) . Alternatively, when a normal acceptor splice site is inactivated by a mutation(s), other neighboring normal splice sites and/or cryptic acceptor-like sequences may be used, which results in the formation of truncated proteins and proteins with internal deletions (Fig 3B) . The latter type could occur since all intron/exon junctions, except the last one, are type I."Such proteins and mRNAs may be unstable.
It is difficult to study the effect of this mutation on the in vivo splicing of pre-mRNA for the b-subunit because it is synthesized in liver and mRNAs of hepatocytes cannot be obtained. In addition, even if there were an ectopically transcribed mRNA for the b-subunit in leukocytes, a fresh blood sample of the proband was not readily available. It is well known that mutations in splice junctions cause the deficiencies of @-globin, lipoprotein lipase, coagulation factor IX, and factor VlII, et^.''-'^ (Fig 4) . Eight additional changes in the nucleotide sequence of the h-subunit gene from the proband were found by sequence analysis when the remaining exons and their flanking regions (-55% of the entire gene for the /)-subunit) were compared with the normal gene (Fig I) . These were all within introns or the 3"mcoding region. Three of these were heterozygous changes and the remaining five were homozygous. Since at least one hctero7ygous mutation has been found in each amplified DNA region. it is concluded that both alleles of the proband's gene coding for the h-subunit have bcen thoroughly examined. and that the significant mutations in this patient are the typc I and I1 mutations.
Replacement of guanosine-I1499 by thymidine in exon VZIZ. When exon VI11 of the proband was sequenced, nine
It is likely that most of these nucleotide changes are polymorphisms between populations." bccausc half' of the eight For (Fig 5R) . whereasthe 155-bp fragment ofthe normal individual remained unchanged. Sequence analysis confirmed that half of the D N A samples from the proband's daughter and son coded for guanosine-l 1499 and the remaining half for thymidine (data not shown). These experiments indicated that the proband. her daughter and son were heterozygous for the type I I mutation. Since both the daughter and son have the type II mutation, but not type 1. it was concluded that one allele of the proband's gene carries the type I mutation and the other allele has the type II mutation. separately (Fig I) .
Thus, the proband turned out to be a compound heterozygote of type I and II mutations in the gene of her imhunit. despite the fact that she was born of a consanguineous marriage between her parents.' Since DNA samples from her parents and other relatives were not available in this study. we could not determine whether these are de novo mutations or inherited from her parents. However. we would predict that her parents carry one each of the two defective alleles. because they are phenotypic heterozygotes.' The fact that a brother of the proband is a phenotypic homozygote also supports this assumption. 
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